Navigation Links
Jazz Pharmaceuticals Pays Accrued Interest Under Senior Secured Notes
Date:7/7/2009

PALO ALTO, Calif., July 7, 2009 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it has paid to the holders of its senior secured notes the interest payments that were due, but not paid, on December 31, 2008, March 31, 2009 and June 30, 2009, for a total payment of approximately $14.6 million. The $119.5 million principal amount of the notes is due in June 2011. Jazz Pharmaceuticals also announced today that it has delivered to the holders of the notes financial statements for the quarter ended June 30, 2009, which indicate that Jazz Pharmaceuticals had achieved as of June 30, 2009 net product sales at the level required to suspend its prior obligation to maintain a minimum cash balance in an account that is pledged to the collateral agent for the notes. The requirement to maintain the account was triggered in May 2009, and Jazz Pharmaceuticals did not, at that time, establish the required account.

Jazz Pharmaceuticals believes that it has cured all material defaults under the agreement governing the notes, and that it will be able to comply with the agreement on an ongoing basis, including payment of future interest payments when due and repayment of the principal amount of the notes when due in June 2011.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information, please see www.jazzpharmaceuticals.com.

Jazz Pharmaceuticals "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forw
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jazz Pharmaceuticals Completes $7 Million Private Placement
2. Biostar Pharmaceuticals, Inc. Commences the Full Implementation of New Rural Cooperative Supply Network Plan
3. ADVENTRX Pharmaceuticals Announces Closing of Financing
4. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
5. Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
6. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
7. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
8. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
9. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
10. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
11. Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... ... ... a hacker gains access to someone’s email account, it can lead to all sorts of ... the FTC issued a scam alert about a social engineering scam which cons a ... instigated by the hacker. All they have to do is click for a password ...
(Date:7/3/2015)... ... 04, 2015 , ... The Harvest Hope Food Bank will hopefully be getting a ... offices in the area of Greenville SC are making it their mission to collect ... only. They are asking for donations from the public as well. As part of the ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Dori Friend opened registration for a new SEO training system called "Page ... guide for organic traffic generation has received glowing reviews from several well-known marketers. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... LENEXA, Kan. (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... FL (October 5, 2011)Approximately 10-20 percent of prostate cancer patients ... three major factors that are used to evaluate the extent ... estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason ... findings (DRE). However, men with a family history of ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Smokers have ... are more likely than men to suffer complications after a ... data on 3,588 patients admitted to the University of Michigan ... attack. About 24 percent of the patients were current smokers. ...
... seven days after a severe head injury results in better ... College of Medicine researchers. This is especially true for patients ... the hospital. A tracheostomy is an opening created in ... allow unimpeded breathing. (A tracheotomy is the act of making ...
... Targets and Cancer Therapeutics will be held from Nov. ... Francisco. This unique conference combines the efforts ... Cancer Institute and the European Organisation for the Research ... of its kind to focus exclusively on issues of ...
... Tool That Helps Identify Prostate Cancer Patients with the ... 4, 2011)After a prostate cancer patient receives radiation treatment, ... or PSA, in his blood. An increase in PSA, ... the cancer,s return to the prostate. Fox Chase Cancer ...
... known to improve motor function in,recovering stroke patients, appear ... units (ICU), new research from Johns,Hopkins suggests. In ... Critical Care ,researchers studied the safety and feasibility of ... ICU. "Patients admitted to our medical intensive care ...
Cached Medicine News:Health News:More aggressive treatment not necessary for men with a family history of prostate cancer 2Health News:Earlier tracheostomies result in better patient outcomes 2Health News:New tool helps identify prostate cancer patients with highest risk of death 2Health News:Practical play: Interactive video games appear valuable for ICU patients 2
(Date:7/3/2015)... , July 3, 2015 ... heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige ... erworben zu haben. Mit dieser Übernahme dringt ... mit einem Umsatz von 765 Mrd. RUB ... Pharmamärkten der Welt gehörte (IMS Health). Seit ...
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
Breaking Medicine Technology:Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... , ATLANTA, Oct. 27 CryoLife, Inc. ... and cardiovascular tissue processing company, today announced that the U.S. ... company,s Investigational Device Exemption (IDE) to conduct a human clinical ... protein hydrogel technology. BioFoam will be used to help ...
... 27 STAAR Surgical Company (Nasdaq: STAA ), a ... today announced today that Deborah Andrews, Chief Financial Officer, will ... Waldorf-Astoria Hotel on Wednesday, November 4th at 3:55 p.m. Eastern ... audio web cast of the presentation at www.staar.com ...
Cached Medicine Technology:CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 2CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 3CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 4CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 5
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... A crisp 2.3 million pixel ... the retinal surface for all ... disc evaluation for glaucoma to ... way to provide filmless, instant ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: